淋巴瘤组织中B7-H4的表达及其临床意义

朱俊锋; 周黎黎; 耿英华; 张凤; 杨艳丽; 夏瑞祥

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

淋巴瘤组织中B7-H4的表达及其临床意义

朱俊锋 , 周黎黎 , 耿英华 , 张凤 , 杨艳丽 , 夏瑞祥

文章导航 > 蚌埠医学院学报 > 2013, 37 > 10: (1288-1290)

引用本文:

Citation:

淋巴瘤组织中B7-H4的表达及其临床意义

1.
1. 安徽医科大学第一附属医院血液科，安徽合肥230022;
2.
2. 蚌埠医学院第一附属医院血液科，安徽蚌埠233004

作者简介: 朱俊锋(1980-) ，男，硕士研究生，主治医师.

通讯作者: 夏瑞祥, xrx2041@163.com

基金项目:

The expression of B7-H4 in lymphoma and its clinical significance

1.
1. Department of Hematology，The First Affiliated Hospital of Anhui Medical University，Hefei Anhui 230022;
2.
2. Department of Hematology，The First Affiliated Hospital of Bengbu Medicial College，Bengbu Anhui 233004，China

Corresponding author: XIA rui-xiang, xrx2041@163.com

摘要: 目的:探讨B7-H4在淋巴瘤组织中的表达及其临床意义。方法:应用EliVision plus免疫组织化学法检测B7-H4在30例非霍奇金淋巴瘤(NHL)、7例霍奇金淋巴瘤(HL)及8例良性增生性淋巴结炎组织中的表达,并分析其与性别、年龄及临床分期的相关性。结果:37例淋巴瘤患者B7-H4阳性率为54.1%,良性增生性淋巴结炎患者阳性率为0/8,差异有统计学意义(P0.05)。NHL患者B7-H4阳性率为56.7%,HL阳性率为3/7,差异无统计学意义(P=0.680)。37例淋巴瘤患者中,Ⅰ/Ⅱ期患者B7-H4阳性率为18.8%,Ⅲ/Ⅳ期患者阳性率为81%,差异有统计学意义(P=0.000 2);不同性别和年龄间B7-H4阳性率差异均无统计学意义(P=0.330和P=0.746)。结论:B7-H4与淋巴瘤的发病有关,可作为淋巴瘤与良性增生性淋巴结炎鉴别的有效指标,但对于HL与NHL的鉴别无临床意义。
- 霍奇金淋巴瘤 /
- 非霍奇金淋巴瘤 /
- 良性增生性淋巴结炎 /
- B7-H4
Abstract: Objective: To investigate the expression of B7-H4 in lymphoma and and its clinical significance. Methods: The expression of B7-H4 in 30 patients with non-Hodgkin lymphoma(NHL) ，7 patients with Hodgkin lymphoma(HL) and 8 patients with benign hyperplastic lymphadenitis were detected using EliVision Plus immunohistochemistry. The correlation of B7-H4 expression with gender, age and disease stage were analyzed by clinical pathology data. results: The positive rate of B7-H4 expression in lymphoma(37 cases) and benign hyperplastic lymphadenitis (8 cases) patients were 54. 1%) and 0. 0%，respectively，the difference of which was statistically significant(P ＜ 0. 05) . The positive rate of B7-H4 expression in NHL and HL patients were 56. 7% and 3 /7, respectively, the difference of which was not statistically significant(P = 0. 680) . The positive rate of B7-H4 expression in stage Ⅰ/Ⅱand Ⅲ/Ⅳ patients were 18. 8% and 81. 0%, respectively, the difference of which was statistically significant(P = 0. 000 2) . The differences of positive rates of B7-H4 expression between gender and age in 37 cases with lymphoma were not statistical significance(P = 0. 330 and P = 0. 746) . Conclusions: The expression of B7-H4 is associated with the pathogenesis of lymphoma，which can be used as an effective index to identify the lymphoma and benign hyperplastic lymphadenitis, and has not clinical value between HL and NHL.
- Hodgkin lymphoma /
- non-Hodgkin lymphoma /
- benign hyperplastic lymphadenitis /
- B7-H4

[1]	Simon I，Zhuo S，Corral L，et al. B7-H4 is a novel membranebound protein and a candidate serum and tissue biomarker for ovarian cancer[J]. Cancer res, 2006，6 6(3): 1570-1575.
[2] Sun Y，Wang Y，Zhao J, et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer[J]. Lung Cancer，2006，53 (2 ): 143-151.
[3] Krambeck AE，Thompson rH，Dong H, et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival[J]. Proc Natl Acad Sci U S A, 2006，1 03(27): 10391-10396.
[4] Miyatake T，Tringler B，Liu W，et al. B7-H4 (DD-O110 ) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration [J]. Gynecol Oncol，2007，1 06(1): 119-127.
[5] Awadallah NS，Shroyer Kr，Langer DA, et al. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct[J]. Pancreas, 2008，3 6(2): 200-206.
[6] Choi IH，Zhu G，Sica GL，et al. Genomic organization and expression analysis of B7-H4，an immune inhibitory molecule of the B7 family[J]. J Immunol，2003, 171(9): 4650-4654.
[7] Kryczek I，Wei S，Zhu G，et al. relationship between B7-H4, regulatory T cells，and patient outcome in human ovarian carcinoma[J]. Cancer res，2007，6 7(18): 8900-8905.
[8] Suh WK，Wang S，Duncan G, et al. Generation and characterization of B7-H4/B7S1/B7x-deficient mice[J]. Mol Cell Biol，2006, 26(17): 6403-6411.
[9] Simon I，Katsaros D，rigault de la longrais I, et al. B7-H4 is overexpressed in early-stage ovarian cancer and is independent of CA125 expression[J]. Gynecol Oncol，2007，106 (2 ): 334-341.
[10] 王小梅，胡国艳，刘伟，等. 血液系统恶性肿瘤患者血清可溶性B7-H4 的检测及其临床意义[J]. 细胞与分子免疫学杂志, 2010, 160(9): 893-897.
[11] 孙玉萍，刘杰，崔霞，等. B7-H4 在结直肠癌组织中表达的临床意义[J]. 山东大学学报: 医学版，2 006，44(6): 590-592.

[1]	徐慧 , 邢琛 , 虞丽莎 , 禹莉 , 郝艳梅 , 李玉云 . 可溶性B7-H4在恶性淋巴瘤中的表达及临床意义. 蚌埠医学院学报, 2015, 40(8): 989-991. doi: 10.13898/j.cnki.issn.1000-2200.2015.08.001
[2]	闵大六 . 霍奇金淋巴瘤研究进展. 蚌埠医学院学报, 2008, 33(6): 710-712.
[3]	王海燕 , 王尚云 , 韦涌涛 . CA125在1例男性非霍奇金淋巴瘤患者中的表达. 蚌埠医学院学报, 2010, 35(7): 752-752.
[4]	杨雯雯 , 查艳芳 , 毛菊 , 胡世莲 , 程民 . 流式细胞术和病理骨髓活检在非霍奇金淋巴瘤骨髓侵犯的诊断价值比较. 蚌埠医学院学报, 2022, 47(2): 227-230. doi: 10.13898/j.cnki.issn.1000-2200.2022.02.023
[5]	谷文文 , 杜丹丽 . HK6和B7-H4在卵巢癌诊断价值的探讨. 蚌埠医学院学报, 2012, 36(6): 684-686.
[6]	黄柱华 , 周争光 , 陈娟 , 赵论 . COMxEP方案治疗非霍奇金淋巴瘤疗效观察. 蚌埠医学院学报, 2006, 31(5): 470-472.
[7]	何素丽 , 杜丹丽 . B7-H4、hK6用于卵巢癌早期诊断的研究进展. 蚌埠医学院学报, 2009, 34(11): 1051-1053.
[8]	苏智祥 , 张燕军 , 刘爱琴 , 王云梅 , 陈文娟 . 替比夫定与恩替卡韦在非霍奇金淋巴瘤合并乙型肝炎病毒感染患者化疗中的抗病毒作用研究. 蚌埠医学院学报, 2016, 41(8): 1000-1002. doi: 10.13898/j.cnki.issn.1000-2200.2016.08.006
[9]	徐方元 , 秦少华 , 杨滢瑜 . 阑尾非何杰金淋巴瘤1例. 蚌埠医学院学报, 2015, 39(7): 989-989. doi: 10.13898/j.cnki.issn.1000-2200.2015.07.060
[10]	封扬 , 胡怀远 , 夏燕 , 吴玲玲 . 桥本甲状腺炎合并原发性甲状腺淋巴瘤4例的临床病理分析. 蚌埠医学院学报, 2016, 41(9): 1214-1217. doi: 10.13898/j.cnki.issn.1000-2200.2016.09.030
[11]	杜维仁 . 原发性脑淋巴瘤的MRI特点. 蚌埠医学院学报, 2007, 32(3): 346-348.
[12]	赖燕 , 刘稳 . 鼻腔鼻窦淋巴瘤8例误诊原因分析. 蚌埠医学院学报, 2013, 37(9): 1158-1160.
[13]	陈颖 , 刘建生 . 原发性结肠淋巴瘤伴肠套叠1例. 蚌埠医学院学报, 2013, 37(5): 609-610.
[14]	章再军 , 周倩 , 吴慧 . 乳腺原发弥漫性大B细胞淋巴瘤2例报道并文献复习. 蚌埠医学院学报, 2011, 36(2): 139-141.
[15]	苏玉璇 , 夏瑞祥 . HIF-1和Bmi-1在弥漫大B细胞淋巴瘤中的表达及意义. 蚌埠医学院学报, 2012, 36(3): 280-283.
[16]	于明雪 , 刘加军 . 高β2微球蛋白对弥漫大B细胞淋巴瘤的临床意义. 蚌埠医学院学报, 2020, 45(8): 1040-1043. doi: 10.13898/j.cnki.issn.1000-2200.2020.08.013
[17]	苏玉璇 , 夏瑞祥 . Bmi-1和c-myc在弥漫大B细胞淋巴瘤中的表达及其意义. 蚌埠医学院学报, 2011, 36(9): 960-963.
[18]	刘伟 , 叶绥艳 , 雷磊 . miR-17-5p及PTEN在弥漫性大B细胞淋巴瘤中的表达及其意义. 蚌埠医学院学报, 2021, 46(12): 1654-1659. doi: 10.13898/j.cnki.issn.1000-2200.2021.12.003
[19]	骆莉莉 , 王欣 . 多发性淋巴瘤性息肉病型套细胞淋巴瘤1例报告并文献复习. 蚌埠医学院学报, 2014, 38(2): 187-189.
[20]	杨振忠 , 法文 , 吕永芳 . 腹壁皮下脂膜炎样T细胞淋巴瘤1例报道并文献复习. 蚌埠医学院学报, 2010, 35(2): 136-139.

点击查看大图

计量

文章访问数: 2888
HTML全文浏览量: 335
PDF下载量: 156
被引次数: 0

淋巴瘤组织中B7-H4的表达及其临床意义

通讯作者: 夏瑞祥, xrx2041@163.com

作者简介: 朱俊锋(1980-) ，男，硕士研究生，主治医师.

1. 1. 安徽医科大学第一附属医院血液科，安徽合肥230022;
2. 2. 蚌埠医学院第一附属医院血液科，安徽蚌埠233004

收稿日期: 2013-04-07
网络出版日期: 2013-10-15

基金项目:

关键词:

摘要: 目的:探讨B7-H4在淋巴瘤组织中的表达及其临床意义。方法:应用EliVision plus免疫组织化学法检测B7-H4在30例非霍奇金淋巴瘤(NHL)、7例霍奇金淋巴瘤(HL)及8例良性增生性淋巴结炎组织中的表达,并分析其与性别、年龄及临床分期的相关性。结果:37例淋巴瘤患者B7-H4阳性率为54.1%,良性增生性淋巴结炎患者阳性率为0/8,差异有统计学意义(P0.05)。NHL患者B7-H4阳性率为56.7%,HL阳性率为3/7,差异无统计学意义(P=0.680)。37例淋巴瘤患者中,Ⅰ/Ⅱ期患者B7-H4阳性率为18.8%,Ⅲ/Ⅳ期患者阳性率为81%,差异有统计学意义(P=0.000 2);不同性别和年龄间B7-H4阳性率差异均无统计学意义(P=0.330和P=0.746)。结论:B7-H4与淋巴瘤的发病有关,可作为淋巴瘤与良性增生性淋巴结炎鉴别的有效指标,但对于HL与NHL的鉴别无临床意义。

English Abstract

The expression of B7-H4 in lymphoma and its clinical significance

Corresponding author: XIA rui-xiang, xrx2041@163.com

1. 1. Department of Hematology，The First Affiliated Hospital of Anhui Medical University，Hefei Anhui 230022;
2. 2. Department of Hematology，The First Affiliated Hospital of Bengbu Medicial College，Bengbu Anhui 233004，China

Received Date: 2013-04-07
Available Online: 2013-10-15

Abstract: Objective: To investigate the expression of B7-H4 in lymphoma and and its clinical significance. Methods: The expression of B7-H4 in 30 patients with non-Hodgkin lymphoma(NHL) ，7 patients with Hodgkin lymphoma(HL) and 8 patients with benign hyperplastic lymphadenitis were detected using EliVision Plus immunohistochemistry. The correlation of B7-H4 expression with gender, age and disease stage were analyzed by clinical pathology data. results: The positive rate of B7-H4 expression in lymphoma(37 cases) and benign hyperplastic lymphadenitis (8 cases) patients were 54. 1%) and 0. 0%，respectively，the difference of which was statistically significant(P ＜ 0. 05) . The positive rate of B7-H4 expression in NHL and HL patients were 56. 7% and 3 /7, respectively, the difference of which was not statistically significant(P = 0. 680) . The positive rate of B7-H4 expression in stage Ⅰ/Ⅱand Ⅲ/Ⅳ patients were 18. 8% and 81. 0%, respectively, the difference of which was statistically significant(P = 0. 000 2) . The differences of positive rates of B7-H4 expression between gender and age in 37 cases with lymphoma were not statistical significance(P = 0. 330 and P = 0. 746) . Conclusions: The expression of B7-H4 is associated with the pathogenesis of lymphoma，which can be used as an effective index to identify the lymphoma and benign hyperplastic lymphadenitis, and has not clinical value between HL and NHL.